SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation. (Q54372505)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 May 2011

Language	Label	Description	Also known as
English	SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation.	scientific article published on 18 May 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

Guido Reifenberger

5

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

author name string

Carina Lindemann

1

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

Oliver Hackmann

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

Sabit Delic

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

Natalie Schmidt

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

Markus J Riemenschneider

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

publication date

18 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

Acta Neuropathologica

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

122

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

241-251

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

The Jak-STAT pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

SOCS3 protein developmentally regulates the chemokine receptor CXCR4-FAK signaling pathway during B lymphopoiesis.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Downregulation of RUNX3 and TES by hypermethylation in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Genetic pathways to primary and secondary glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

STAT-mediated EGFR signaling in cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Molecular diagnostics of gliomas: state of the art.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Molecular neuropathology of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activation

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

STATs in cancer inflammation and immunity: a leading role for STAT3

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Restoration of SOCS3 suppresses human lung adenocarcinoma cell growth by downregulating activation of Erk1/2, Akt apart from STAT3.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0832-0

21 January 2018

Identifiers

10.1007/S00401-011-0832-0

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21590492

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54372505&oldid=2212443069"